Publications by authors named "Beata Bode"

Claim this Profile
M
Myxoinflammatory Fibroblastic Sarcoma, Nodular-Necrotizing Variant With Two YAP1::MAML2 Fusions and TRIM24::BRAF Fusion.
Kim Harnisch, Beata Bode, Obinna Chijioke, Ivana Bratic Hench, Dmitry V Kazakov

Am J Dermatopathol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An epithelioid hemangioendothelioma with a novel RREB1::TFE3 gene fusion.
Thomas Schumacher, Baptiste Ameline, Alexander Vogetseder, Beata Bode, Teodor Svantesson

Virchows Arch· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects.
Silvia Hofer, Chantal Pauli, Beata Bode, Sylvie Bonvalot, Christina Fotopoulou

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Ultrahypofractionated Radiation Therapy for Soft Tissue Sarcomas: Low Rate of Wound Complications.
Alexander Mattmann, Christoph Glanzmann, Bruno Fuchs, Beata Bode, Gabriela Studer

Adv Radiat Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation.
Philip Heesen, Georg Schelling, Mirko Birbaumer, Ruben Jäger, Beata Bode

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transdisciplinary sarcoma care: a model for sustainable healthcare transformation.
Bruno Fuchs, Beata Bode, Philip Heesen, Barbara Kopf, Christian Michelitsch

Swiss Med Wkly· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xanthogranulomatous epithelial tumor: a novel entity of uncertain biologic potential.
Teodor Svantesson, Kim van Oudenaarde, Bruno Fuchs, Beata Bode, Alexander Vogetseder

Arch Clin Cases· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Sarcoma-Specific Instrument to Longitudinally Assess Health-Related Outcomes of the Routine Care Cycle.
Nasian Mosku, Philip Heesen, Salome Christen, Mario F Scaglioni, Beata Bode

Diagnostics (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors.
Christiane Palm, Catherine E Connolly, Regina Masser, Barbara Padberg Sgier, Eva Karamitopoulou, Beata Bode

Diagnostics (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report.
Veronika Blum, Vanghelita Andrei, Baptiste Ameline, Silvia Hofer, Bruno Fuchs, Beata Bode

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Sarcoma Care: Longitudinal Real-Time Assessment and Evidence Analytics of Quality Indicators.
Philip Heesen, Gabriela Studer, Beata Bode, Hubi Windegger, Benjamin Staeheli

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopsy Ratio of Suspected to Confirmed Sarcoma Diagnosis.
Nasian Mosku, Philip Heesen, Gabriela Studer, Beata Bode, Vito Spataro

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
Josephine K Dermawan, Elizabeth M Azzato, Steven D Billings, Karen J Fritchie, Sebastien Aubert, Beata Bode

Mod Pathol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a value-based healthcare delivery model for sarcoma patients.
Bruno Fuchs, Gabriela Studer, Beata Bode, Hanna Wellauer, Annika Frei

Swiss Med Wkly· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological and histological findings in ancient salt mummies from the salt mine of Douzlākh, Iran.
Lena Maria Öhrström, Herman Marquez, Roger Seiler, Beata Bode, Abolfazl Aali

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized workflow for digitalized FISH analysis in pathology.
Vira Chea, Valerie Pleiner, Viviane Schweizer, Benjamin Herzog, Beata Bode

Diagn Pathol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies.
David O Azorsa, Peter K Bode, Marco Wachtel, Adam Tai Chi Cheuk, Paul S Meltzer, Beata Bode

Mod Pathol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A Mutation.
Niels J Rupp, Muriel Brada, Alena Skálová, Beata Bode, Martina A Broglie

Head Neck Pathol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015.
Attila Kollár, Christian Rothermundt, Frank Klenke, Beata Bode, Daniel Baumhoer

Cancer Epidemiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kaposi Sarcoma of the Ear in HIV-Negative Patients.
Niels J Rupp, Beata Bode, Martina A Broglie, Grégoire B Morand

Head Neck Pathol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients.
Paulino Tallón de Lara, Virginia Cecconi, Stefanie Hiltbrunner, Hideo Yagita, Martina Friess, Beata Bode

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 49-year old female with multiple extra-axial tumors.
Marian C Neidert, Henning Leske, Karl Frontzek, Beata Bode, David Capper

Brain Pathol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Nadezda P Velizheva, Markus P Rechsteiner, Christine E Wong, Qing Zhong, Matthias Rössle, Beata Bode

Cancer Cytopathol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?
Richard Cathomas, Christian Rothermundt, Beata Bode, Bruno Fuchs, Roger von Moos

Oncology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy.
Chantal Pauli, Bruno Fuchs, Christian Pfirrmann, Julia A Bridge, Silvia Hofer, Beata Bode

World J Surg Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis